EDX Medical Group Plc
EDX · AIM · Health Care · mcap £38m · 8.0p
Directors
purchase EDX Medical Group plc announced that Chief Executive Officer Dr. Michael Hudson purchased 28,526 ordinary shares at an average price of 10.57 pence, increasing his holding to 20,600,000 shares, and a closely associated p 23 Dec 2025
purchase EDX Medical Group PLC announced that Professor Sir Christopher Evans, founder and Chief Scientific Officer, purchased 57,304 ordinary shares on December 31, 2025, at 11.49 pence per share, increasing his total holding to 2 Jan 2026
purchase EDX Medical Group plc announced that Professor Sir Christopher Evans, founder and Chief Scientific Officer, purchased 45,500 ordinary shares at 10.75 pence per share on January 2, 2026. This follows a previous purchase o 5 Jan 2026
purchase EDX Medical Group PLC announced that its Chairman, Jason Holt, purchased a total of 200,000 ordinary shares on January 5, 2026, at an average price of 11.42 pence per share, comprising 150,000 shares at 11.23 pence and 5 6 Jan 2026
purchase EDX Medical Group plc announced that its Chairman, Jason Holt, purchased 235,000 ordinary shares at 11.40 pence per share on January 7, 2026, following a prior purchase of 200,000 shares. This transaction brings Mr. Holt 8 Jan 2026
purchase EDX Medical Group plc announced that Professor Sir Christopher Evans, founder and Chief Scientific Officer, purchased 41,780 ordinary shares on January 8, 2026, at 13.00 pence per share, following previous share purchase 9 Jan 2026
purchase EDX Medical Group plc has announced changes in major shareholdings due to dilution from a recent equity fundraising. Dr. Michael Hudson, CEO, and his associates now hold 20,650,000 ordinary shares, representing 4.79% of 4 Sep 2026
Company filings. Not investment advice.